Trials / Unknown
UnknownNCT00694278
Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes
Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes in Adults
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (estimated)
- Sponsor
- Ferzli, George S., M.D. F.A.C.S. · Individual
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study and the primary outcome is to clinically evaluate effect of laparoscopic duodenal-jejunal bypass on non-obese type 2 diabetes. Secondary outcomes will evaluate CCK, FFA, Cholesterol Ghrelin, C-peptide, and HbA1c levels. Patients will be followed closely to ensure the desired results are sustained in long term
Conditions
Timeline
- Start date
- 2008-06-01
- First posted
- 2008-06-10
- Last updated
- 2008-06-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00694278. Inclusion in this directory is not an endorsement.